Related Experiment Video
Updated: Aug 11, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Evidence against the hypothesis that BCL-2 inhibits apoptosis through an anti-oxidant effect
1Department of Medicine, VA West Los Angeles Hospital-UCLA Medical Center, Los Angeles, California, USA.
Abstract:
We contrasted possible protection against apoptosis afforded by either BCL-2 expression or anti-oxidant inhibitors in the same tumor target challenged by two distinct triggers of apoptosis. Exposure of L929 fibroblasts to tumor necrosis factor (TNF) or etoposide (VP-16) induced apoptotic death with similar kinetics. Enforced expression of BCL-2 significantly protected against apoptosis induced by VP-16 but had no effect against TNF-induced apoptosis. In contrast, the anti-oxidants desferrioxamine, butylated hydroxyanisol and N-acetyl cysteine all inhibited TNF-induced apoptosis in a concentration-dependent fashion. Although exposure to VP-16 resulted in a significant generation of intracellular oxyradicals, the above three anti-oxidant inhibitors had no effect on VP-16-induced apoptotic death. Interestingly, enforced expression of BCL-2 also inhibited the ability of VP-16 to generate oxy-radicals and to depress intracellular glutathione levels. These results indicate that BCL-2 can exert anti-oxidant effects but argue against the hypothesis that these effects are critical to its protection against apoptosis.
Insights
BCL-2 protein protects against etoposide-induced apoptosis, while antioxidants block tumor necrosis factor (TNF)-induced apoptosis. BCL-2 shows antioxidant effects, but this is not key to its anti-apoptotic function.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, is a critical cellular process.
- The BCL-2 protein family plays a key role in regulating apoptosis.
- Oxidative stress, indicated by intracellular oxyradicals, is implicated in apoptosis.
Purpose of the Study:
- To investigate the protective mechanisms of BCL-2 expression versus antioxidant inhibitors against apoptosis.
- To determine if BCL-2's anti-apoptotic function is mediated by its antioxidant effects.
Main Methods:
- L929 fibroblasts were exposed to two apoptosis inducers: tumor necrosis factor (TNF) and etoposide (VP-16).
- Protection was assessed using enforced BCL-2 expression and various antioxidant inhibitors (desferrioxamine, butylated hydroxyanisole, N-acetyl cysteine).
- Intracellular oxyradical generation and glutathione levels were measured.
Main Results:
- BCL-2 expression protected against VP-16-induced apoptosis but not TNF-induced apoptosis.
- Antioxidants inhibited TNF-induced apoptosis in a dose-dependent manner but did not affect VP-16-induced apoptosis.
- VP-16 induced oxyradical generation, which was inhibited by BCL-2 expression; BCL-2 also prevented glutathione depletion.
Conclusions:
- BCL-2 exhibits antioxidant properties, interfering with VP-16-induced oxidative stress.
- Despite its antioxidant effects, these are not the primary mechanism for BCL-2's protection against VP-16-induced apoptosis.
- Distinct pathways mediate apoptosis triggered by TNF and VP-16, with differential sensitivity to BCL-2 and antioxidants.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Caspases
Abnormal Proliferation
